Dokumendiregister | Terviseamet |
Viit | 8.1-2/24/6982-2 |
Registreeritud | 02.09.2024 |
Sünkroonitud | 03.09.2024 |
Liik | Sissetulev dokument |
Funktsioon | 8.1 Nakkushaiguste seire, ennetuse ja tõrje korraldamine |
Sari | 8.1-2 Nakkushaiguste epidemioloogiaalane riigiväline kirjavahetus |
Toimik | 8.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | ARHAI Meetings |
Saabumis/saatmisviis | ARHAI Meetings |
Vastutaja | Kärt Sõber (TA, Peadirektori asetäitja (1) vastutusvaldkond, Nakkushaiguste epidemioloogia osakond) |
Originaal | Ava uues aknas |
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear colleague,
This email is a reminder to register to participate in the virtual network meeting of the ECDC European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net).
Invitees are required to register in the EUSurvey tool (URL: https://ec.europa.eu/eusurvey/runner/3e2c8331-45d3-54d6-4de9-37b4d4aef504). Please note that this invitation is personal and non-transferable.
Please indicate whether you are planning to attend the first or second day or both days of the meeting:
·
Wednesday, 25 September 2024, 10:00 – 16:00 CET
Topics: General interest topics; ECDC CCRE Focus.
Requirements for participants: registration on EUSurvey (see above); and a valid aDoI (see below)
·
Thursday, 26 September 2024, 10:00 – 17:00 CET
Topic: ‘Kick-off meeting’ for the ECDC survey of carbapenem-resistance
Acinetobacter baumannii (CRAb) 2024–2025 (draft agenda attached).
Requirements for participants: registration on EUSurvey (see above). No aDoI is required.
Those who wish to attend day 1 of the meeting (25 September) are required to have a valid annual Declaration of Interests (aDoI) at the time of the meeting, in accordance with the ECDC policy on scientific integrity and independence. This is to ensure that there are no conflicts of interest which could impair the independence of ECDC’s activities.
People who register in EUSurvey, but do not have a valid aDoI by 13 September 2024 will only receive the joining instructions for the day 2 of the meeting. Participants on day 2 do not need aDoIs, because the meeting will discuss the published materials for the upcoming CRAb survey.
For those who wish to join day 1:
If you have any questions, or if we can support you in some way, please email [email protected] .
Kind regards,
ECDC EURGen-Net team
|
Confidentiality Notice
If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
Classified as ECDC NORMAL
Draft Agenda 25-26 September 2024 1/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) network meeting 2024
25-26 September 2024
Draft Agenda
Draft Agenda 25-26 September 2024 2/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
Scope and purpose The purpose of this virtual meeting is to provide the EURGen-Net Operational Contact Points (and Contact Points for Operations) and the National Focal Points for Antimicrobial Resistance (and Observer National Focal Points for Antimicrobial Resistance) with updates on ongoing ECDC activities related to molecular surveillance. Day 1 will provide updates on current and potential activities related to CCRE. Day 2 is the ‘kick-off meeting’ for the ‘ECDC survey of carbapenem-resistant Acinetobacter baumannii 2024/2025’, presenting and discussing the published ECDC survey protocol and laboratory manual.
Wednesday 25 September 2024
ECDC CCRE Focus (break times TBA)
10:00-11:15 EURGen-Net Network meeting: Welcome and introduction
11:25-12:30 CCRE morning session
13:30-16:00 CCRE afternoon session
Draft Agenda 25-26 September 2024 3/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
Thursday 26 September 2024
Day 2 of the EURGen-Net network meeting is the kick-off meeting for the ECDC CRAb survey, 2024—2025, which has a survey period from 01/10/2024—30/06/2025. Attendees can propose topics for interactive sessions in ≥ 3 ways:
1. During the meeting using the chat, or by speaking.
2. Before the meeting by email (to: [email protected]; [email protected]). At the meeting, ECDC will not share the names the people who sent the emails.
3. Preferably by 13 September, using an anonymous & short online ECDC survey. URL: https://ec.europa.eu/eusurvey/publication/CRAb_kickoff_meeting_survey
09:30 Virtual room opens
INITIAL SESSION (10:00–11:10)
10:00 Welcome; launch of survey; CRAb-survey-related updates; adoption of the meeting agenda. Pete Kinross (ECDC)
10:10 Brief overview of the survey materials, i.e. the survey protocol, the laboratory manual, and (Excel) data entry tool.
Pete Kinross, Andreas Hoefer (ECDC)
10:15 Brief practical presentation of the Excel data entry tool Pete Kinross (ECDC)
10:20 Immediate questions and requests for clarification Group (ECDC moderates)
10:30 An introduction from Institut Pasteur, the ECDC contractor for strain collection for the CRAb-survey
Mariana FERRARI, Fay BETSOU (CRBIP, Paris, FR)
10:50 Summary of all CRAb survey-related ‘frequently asked questions’ (FAQs); Introduction to the main session and afternoon session.
Pete Kinross; Andreas Hoefer (ECDC)
11:00 Immediate questions, and requests for clarification; and gather additional topics for the next sessions
Group (ECDC moderates)
11:10 Coffee break
MAIN Q&A SESSION (11:30–12:30) Note: you can propose topics now using the EUSurvey hyperlink*
11:30 Open floor Q&A session Group (ECDC moderates)
12:20 Summary of meeting and next steps; close of meeting. Pete Kinross; Andreas Hoefer (ECDC)
12:30 End of meeting. Note: the virtual room will remain open from 12:30–13:30 ECDC remains online 13:30 Virtual meeting room closes 13:55 Virtual meeting room reopens
OPTIONAL AFTERNOON GROUP SESSIONS OR BILATERAL SESSIONS (14:00–17:00) Note: visit the EUSurvey hyperlink* to request topic(s) and/or a bilateral meeting; and indicate your available times
14:00 Optional session 1 ECDC moderates 14:30 Optional session 2 ECDC moderates 15:00 Optional session 3 ECDC moderates 15:30 Optional session 4 ECDC moderates 16:00 Optional session 5 ECDC moderates 16:30 Coffee break
16:45 Review of afternoon session; summary of next steps. Pete Kinross; Andreas Hoefer (ECDC)
17:00 End of optional afternoon session ECDC remains online 17:15 Virtual meeting room closes
1/1 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
ECDC
Submission of Annual Declaration of Interest
Dear Expert,
You are sent this document because you participate in ECDC activities in which your evidence, expert opinion and advice may influence the scientific position of ECDC. In accordance to ECDC's Founding Regulation, we are required to ensure independence, high scientific quality, transparency and efficiency. To maintain all the aforementioned, both in scientific advice and in the day-to-day operations, ECDC has developed its Independence Policy and implementing rules on declarations of interest. As part of this policy, experts are required to submit a Declaration of Interests (DoI) in those situations where the scientific independence of ECDC needs to be safeguarded. Herewith we ask you to submit an Annual Declaration of Interests (ADoI) that will be valid for one year from the day of confirmation, and can be used for any type of your involvement in ECDC activities requiring check for potential conflict of interests.
ECDC has developed an electronic submission system for ADoI. To submit your declaration, you need to open the eDoI Application, sign in and perform the following steps:
• Click on “Add/Edit Declaration” to start filling in your ADoI; • Click on “I Agree” to agree with terms and conditions of Data Protection Notice; • Answer all questions in the online form that are relevant to you. It is possible to return to completing
the form at a later stage if you cannot provide all answers at once. To do so, click on “Save and come back later”;
• When done, choose a way to be notified to confirm the information you filled in, and click on “Submit to proceed to confirmation”;
• If you chose to confirm the submitted declaration via email, find in your inbox an automatic email with a validation link (check your spam or junk folder if you cannot find the email in your inbox folder). Click on the validation link, sing in and click on “Confirm” to complete the process;
• If you chose to confirm submitted declaration via sms, enter a code sent to you in a sms and click on “Confirm” to complete the process;
• Once confirmed, you will receive an automatic email with your ADoI attached as a PDF file.
Do not hesitate to contact our Helpdesk at [email protected] if you experience any technical problems.
Draft Agenda 25-26 September 2024 1/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
European Antimicrobial Resistance Genes Surveillance Network (EURGen-Net) network meeting 2024
25-26 September 2024
Draft Agenda
Draft Agenda 25-26 September 2024 2/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
Scope and purpose The purpose of this virtual meeting is to provide the EURGen-Net Operational Contact Points (and Contact Points for Operations) and the National Focal Points for Antimicrobial Resistance (and Observer National Focal Points for Antimicrobial Resistance) with updates on ongoing ECDC activities related to molecular surveillance. Day 1 will provide updates on current and potential activities related to CCRE. Day 2 is the ‘kick-off meeting’ for the ‘ECDC survey of carbapenem-resistant Acinetobacter baumannii 2024/2025’, presenting and discussing the published ECDC survey protocol and laboratory manual.
Wednesday 25 September 2024
ECDC CCRE Focus (break times TBA)
10:00-11:15 EURGen-Net Network meeting: Welcome and introduction
11:25-12:30 CCRE morning session
13:30-16:00 CCRE afternoon session
Draft Agenda 25-26 September 2024 3/3 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
Thursday 26 September 2024
Day 2 of the EURGen-Net network meeting is the kick-off meeting for the ECDC CRAb survey, 2024—2025, which has a survey period from 01/10/2024—30/06/2025. Attendees can propose topics for interactive sessions in ≥ 3 ways:
1. During the meeting using the chat, or by speaking.
2. Before the meeting by email (to: [email protected]; [email protected]). At the meeting, ECDC will not share the names the people who sent the emails.
3. Preferably by 13 September, using an anonymous & short online ECDC survey. URL: https://ec.europa.eu/eusurvey/publication/CRAb_kickoff_meeting_survey
09:30 Virtual room opens
INITIAL SESSION (10:00–11:10)
10:00 Welcome; launch of survey; CRAb-survey-related updates; adoption of the meeting agenda. Pete Kinross (ECDC)
10:10 Brief overview of the survey materials, i.e. the survey protocol, the laboratory manual, and (Excel) data entry tool.
Pete Kinross, Andreas Hoefer (ECDC)
10:15 Brief practical presentation of the Excel data entry tool Pete Kinross (ECDC)
10:20 Immediate questions and requests for clarification Group (ECDC moderates)
10:30 An introduction from Institut Pasteur, the ECDC contractor for strain collection for the CRAb-survey
Mariana FERRARI, Fay BETSOU (CRBIP, Paris, FR)
10:50 Summary of all CRAb survey-related ‘frequently asked questions’ (FAQs); Introduction to the main session and afternoon session.
Pete Kinross; Andreas Hoefer (ECDC)
11:00 Immediate questions, and requests for clarification; and gather additional topics for the next sessions
Group (ECDC moderates)
11:10 Coffee break
MAIN Q&A SESSION (11:30–12:30) Note: you can propose topics now using the EUSurvey hyperlink*
11:30 Open floor Q&A session Group (ECDC moderates)
12:20 Summary of meeting and next steps; close of meeting. Pete Kinross; Andreas Hoefer (ECDC)
12:30 End of meeting. Note: the virtual room will remain open from 12:30–13:30 ECDC remains online 13:30 Virtual meeting room closes 13:55 Virtual meeting room reopens
OPTIONAL AFTERNOON GROUP SESSIONS OR BILATERAL SESSIONS (14:00–17:00) Note: visit the EUSurvey hyperlink* to request topic(s) and/or a bilateral meeting; and indicate your available times
14:00 Optional session 1 ECDC moderates 14:30 Optional session 2 ECDC moderates 15:00 Optional session 3 ECDC moderates 15:30 Optional session 4 ECDC moderates 16:00 Optional session 5 ECDC moderates 16:30 Coffee break
16:45 Review of afternoon session; summary of next steps. Pete Kinross; Andreas Hoefer (ECDC)
17:00 End of optional afternoon session ECDC remains online 17:15 Virtual meeting room closes
1/1 European Centre for Disease Prevention and Control (ECDC) Gustav den III:s Boulevard 40, 169 73 Solna, Sweden Phone: +46 (0)8 58 60 10 00 - Fax: +46 (0)8 58 60 10 01
www.ecdc.europa.eu
ECDC
Submission of Annual Declaration of Interest
Dear Expert,
You are sent this document because you participate in ECDC activities in which your evidence, expert opinion and advice may influence the scientific position of ECDC. In accordance to ECDC's Founding Regulation, we are required to ensure independence, high scientific quality, transparency and efficiency. To maintain all the aforementioned, both in scientific advice and in the day-to-day operations, ECDC has developed its Independence Policy and implementing rules on declarations of interest. As part of this policy, experts are required to submit a Declaration of Interests (DoI) in those situations where the scientific independence of ECDC needs to be safeguarded. Herewith we ask you to submit an Annual Declaration of Interests (ADoI) that will be valid for one year from the day of confirmation, and can be used for any type of your involvement in ECDC activities requiring check for potential conflict of interests.
ECDC has developed an electronic submission system for ADoI. To submit your declaration, you need to open the eDoI Application, sign in and perform the following steps:
• Click on “Add/Edit Declaration” to start filling in your ADoI; • Click on “I Agree” to agree with terms and conditions of Data Protection Notice; • Answer all questions in the online form that are relevant to you. It is possible to return to completing
the form at a later stage if you cannot provide all answers at once. To do so, click on “Save and come back later”;
• When done, choose a way to be notified to confirm the information you filled in, and click on “Submit to proceed to confirmation”;
• If you chose to confirm the submitted declaration via email, find in your inbox an automatic email with a validation link (check your spam or junk folder if you cannot find the email in your inbox folder). Click on the validation link, sing in and click on “Confirm” to complete the process;
• If you chose to confirm submitted declaration via sms, enter a code sent to you in a sms and click on “Confirm” to complete the process;
• Once confirmed, you will receive an automatic email with your ADoI attached as a PDF file.
Do not hesitate to contact our Helpdesk at [email protected] if you experience any technical problems.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|